Radiation Oncology · Sarasota, FL
NPI
1235240664
Since 2006
Specialty
Radiation Oncology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2803 Fruitville Rd, Suite 1
Sarasota, FL, 34237
Phone (941) 957-4926
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
11,854 services
Medicare patients, 2024
497
Average age 77
Drug cost, 2024
$2.0M
3,003 prescriptions
Company payments, 2025
$1,028
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael J Dattoli was code J0897 (injection, denosumab, 1 mg), 5,280 times for 29 patients. In total Michael J Dattoli billed 11,854 services in 39 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 5,280 | 29 | $20.36 | $108K |
| G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 1,310 | 47 | $263.60 | $345K |
| G6017 Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment | Office | 1,308 | 47 | $59.90 | $78K |
| 77300 Radiation Treatment Planning | Office | 628 | 41 | $50.35 | $32K |
| 77290 Radiation Treatment Planning | Office | 423 | 385 | $314.56 | $133K |
| 76872 Ultrasound - Nonspecific | Office | 410 | 370 | $96.35 | $40K |
| 93980 Duplex Scan - Extremity Arteries | Office | 409 | 369 | $83.63 | $34K |
| 99215 Office E&M - Established | Office | 388 | 345 | $137.40 | $53K |
| 77427 Conventional Radiation Treatment | Office | 258 | 49 | $149.42 | $39K |
| 77336 Radiation Treatment Planning | Office | 250 | 45 | $66.41 | $17K |
| J3315 Injection, triptorelin pamoate, 3.75 mg | Office | 157 | 26 | $344.93 | $54K |
| 36415 Venipuncture Blood Collection | Office | 115 | 99 | $8.65 | $995 |
| 77338 Radiation Treatment Planning | Office | 110 | 41 | $357.25 | $39K |
| 74176 CT/CTA - Abdomen and Pelvis | Office | 108 | 77 | $132.98 | $14K |
| 71250 CT/CTA - Chest | Office | 108 | 78 | $69.57 | $7,514 |
By year: 2022 $826K for 9,947 services; 2023 $1.1M for 12,872 services; 2024 $1.5M for 11,854 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 115 | 99 | $8.65 | $995 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael J Dattoli prescribed most often to Medicare patients was Dutasteride, with 436 prescriptions and refills. In total Michael J Dattoli wrote 3,003 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dutasteride Generic | 436 | 977 | 127 | $13K |
| Tamsulosin Hcl Generic | 411 | 1,031 | 150 | $8,503 |
| Cabergoline Generic | 302 | 591 | 73 | $29K |
| Pentoxifylline Generic | 235 | 603 | 98 | $10K |
| Metformin Hcl Generic | 190 | 507 | 67 | $1,236 |
| Estradiol (Twice Weekly) Estradiol | 186 | 284 | 50 | $14K |
| Finasteride Generic | 183 | 491 | 60 | $3,426 |
| Bicalutamide Generic | 125 | 236 | 48 | $2,793 |
| Celecoxib Generic | 93 | 187 | 25 | $1,611 |
| Erleada Apalutamide | 86 | 114 | 15 | $1.3M |
| Tadalafil Generic | 67 | 181 | 20 | $3,954 |
| Rosuvastatin Calcium Generic | 64 | 192 | 21 | $970 |
| Doxazosin Mesylate Generic | 60 | 176 | 30 | $1,893 |
| Dotti Estradiol | 51 | 91 | 22 | $5,350 |
| Abiraterone Acetate Generic | 49 | 49 | Under 11 | $40K |
Brand drugs: - claims; generic drugs: 2,684 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael J Dattoli $1,028 ($1,028 in general payments such as food, travel and fees) from 14 companies. The largest payer was Dendreon Pharmaceuticals LLC with $193.
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 8 | $193 |
| Janssen Biotech, Inc. JNJ | 12 | $166 |
| Pfizer Inc. PFE | 7 | $164 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $143 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $74.81 |
| Astellas Pharma US Inc 4503.T | 3 | $58.92 |
| Tolmar, Inc. | 3 | $54.66 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $37.08 |
| Boston Scientific Corporation BSX | 1 | $27.82 |
| Progenics Pharmaceuticals, Inc. | 1 | $27.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.